HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin is being tested for CVD, cancer and Alzheimer's, but mechanisms are unclear

Louis Nervegna · Mar 08, 2024 · ♥ 14 reactions · 8 comments · original Facebook post
Insulin resistance & diabetesAging & longevity
AI summary & key facts

Louis shares a Medscape article on renewed academic interest in metformin for conditions beyond diabetes, including cardiovascular, neurodegenerative, liver, kidney disease and cancers. Many new trials are underway, and it is unclear whether benefits come from glucose lowering and insulin sensitizing or other actions like mTOR inhibition. This is emerging, not established, evidence.

Feb 27, 2024 — Metformin might protect against CVD, cancer, Alzheimer’s, and a number of other diseases.

In academia, there has been a recent resurgence of interest in metformin for these purposes, and several new trials have begun.

Quoted:

“Emerging evidence suggests the drug may be effective for a much broader range of conditions beyond managing high blood glucose, including various cancers, obesity, liver disease, cardiovascular, neurodegenerative, and renal diseases. As the evidence for diverse uses accumulates, many trials have launched, with researchers looking to expand metformin's indications and validate or explore new directions.”

“Collectively, these data raise the question: Is metformin a drug for all diseases? It remains unclear as to whether all of these putative beneficial effects are secondary to its actions as an antihyperglycemic and insulin-sensitizing drug, or result from other cellular actions, including inhibition of mTOR (mammalian target for rapamycin), or direct antiviral actions."

MedscapeIs Metformin a 'Drug for All Diseases'?Metformin, a staple of glucose management for decades, is now being studied for use in a wide range of diseases from carotid atherosclerosis to vitiligo.medscape.com

#metforminHD #agingHD #longevityHD

MedscapeIs Metformin a 'Drug for All Diseases'?Metformin, a staple of glucose management for decades, is now being studied for use in a wide range of diseases from carotid atherosclerosis to vitiligo.medscape.com

Research cited

← newer: Video: why ApoB is a better CVD risk marker than LDL-C and wolder: Citrus bergamot appears safe to combine with a statin, per D →